Ibritumomab tiuxetan

CAT#: TP-106CL

Indium or yttrium conjugated murine IgG1 kappa monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes. Ibritumomab is produced in Chinese hamster ovary cells and is composed of two murine gamma 1 heavy chains of 445 amino acids each and two kappa light chains of 213 amino acids each.

Specifications

  • Type
  • Biotech
  • Trade name
  • Zevalin
  • UNII
  • 4Q52C550XK

Target

  • Function
  • A mAb portion that recognizes CD20+ B cells and induces apoptosis while the chelation site allows either imaging (In-111) or cellular damage by beta emission (Y-90)
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TP-106CL. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
High Specificity For CD20 Antigen
Our lab utilized this Indium or yttrium conjugated murine antibody to target the CD20 antigen on B lymphocytes. The specificity for the CD20+ B cells was impressive, and the conjugation facilitated our imaging protocols effectively. The recombinant production in CHO cells seems to ensure high quality.
Breast cancer biomarkers at key points during disease progression
Excellent Conjugated Monoclonal Antibody
We were looking for a murine IgG1 kappa monoclonal antibody that interacts with the CD20 antigen for our cellular studies. This Ibritumomab tiuxetan product performed exactly as described. The chelation site's capability for isotope conjugation was a key feature that supported our experimental design involving cellular interaction analysis.

Q&As

  1. What is the composition and host source of this antibody?

    A: This is an Indium or yttrium conjugated murine monoclonal antibody. It is produced in Chinese hamster ovary (CHO) cells and is composed of two murine gamma 1 heavy chains and two kappa light chains.

  2. What is the specific target of this antibody?

    A: The antibody is directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes. It is designed to recognize CD20+ B cells and can induce apoptosis or be used for imaging via its chelation site.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare

Merry Christmas & Happy New Year
Happy Thanksgiving close ad